BioPharma Credit PLC Correction: Final Results of Issue (0722E)
03 May 2017 - 11:05PM
UK Regulatory
TIDMBPCR
RNS Number : 0722E
BioPharma Credit PLC
03 May 2017
BIOPHARMA CREDIT PLC
CORRECTION: FINAL RESULTS OF ISSUE
The Company announces that certain details contained within the
"Final Results of Issue" announcement released on 23 March 2017 at
7:02 under RNS No 2921A require amendment following final
determination of the relevant figures as follows:
-- The PL Associates hold 106,139,245 Shares accounting for
proceeds of US$106,139,245 or c.13.93% of the Gross Issue Proceeds
and not 106,209,484 Shares accounting for proceeds of
US$106,209,484 or c.13.94% of the Gross Issue Proceeds.
-- Mr. Pablo Legorreta acquired 3,268,808 Shares through the
BioPharma III Interest and not 3,325,000 Shares.
-- Mr. Pedro Gonzalez de Cosio acquired 163,441 Shares through
the BioPharma III Interest and not 166,250 Shares.
-- Mrs. Almudena Legorreta acquired 653,762 Shares through the
BioPharma III Interest and not 665,000 Shares.
-- 26,679,844 Shares were issued to members of the PL Associates
on Initial Admission pursuant to the PL Subscription and the
BioPharma III Tender Offer and not 26,750,083 Shares.
-- The reference to the potential increase in the PL Associates
shareholding following a repurchase by the Company of its own
Shares should be to 16.39% and not 16.40%.
All other details remain unchanged. Terms not otherwise defined
herein have the meaning given to them in the "Final Results of
Issue" announcement released on 23 March 2017 at 7:02 under RNS No
2921A.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFIFEIIVIID
(END) Dow Jones Newswires
May 03, 2017 09:05 ET (13:05 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024